Study to Evaluate and Compare Safety and Pharmacokinetics of the HCP1004 and VIMOVO 500/20mg in Healthy Korean Male

NCT01688193 · clinicaltrials.gov ↗
COMPLETED
Status
68
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Hanmi Pharmaceutical Company Limited